The Claim
Among pregnant women receiving antenatal supplements containing 60 mg of iron, there is no statistically significant difference in neonatal mortality between those receiving multiple micronutrient supplements and those receiving iron-folic acid supplements.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When pregnant women take antenatal supplements with 60 mg of iron, neonatal mortality rates are the same whether they take multiple micronutrient supplements or iron-folic acid supplements.
See the scientific wording
There is no statistically significant difference in neonatal mortality between antenatal multiple micronutrient supplements and iron-folic acid supplements when both contain 60 mg of iron, based on pooled data from multiple randomized trials, indicating that higher iron content in MMS does not confer additional benefit or risk for newborn survival.
When pregnant women take either supplement with 60 mg of iron, the placenta delivers the same amount of iron to the baby, and other nutrients in the multivitamin do not change how much iron reaches the fetus or how well the baby survives after birth.
What the research says
1 studyWhen pregnant women take either a multivitamin pill or just iron and folic acid—both with the same 60 mg of iron—babies are just as likely to survive the first month. The study found no difference in baby deaths between the two types of pills.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.